GC Biopharma Corp. (KRX: 006280)

GC Biopharma Revenue

GC Biopharma had revenue of 464.87B KRW in the quarter ending September 30, 2024, with 5.81% growth. This brings the company's revenue in the last twelve months to 1.64T, up 0.66% year-over-year. In the year 2023, GC Biopharma had annual revenue of 1.63T, down -4.95%.

• Revenue (ttm): 1,643.98B
• Revenue Growth: +0.66%
• P/S Ratio: 1.16
• Revenue / Employee: 818.31M
• Employees: 2,009
• Market Cap: 1,902.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,626.64B	-84.67B	-4.95%
Dec 31, 2022	1,711.31B	173.49B	11.28%
Dec 31, 2021	1,537.83B	33.71B	2.24%
Dec 31, 2020	1,504.12B	147.00B	10.83%
Dec 31, 2019	1,357.12B	22.24B	1.67%